Literature DB >> 8264874

Familial subarachnoid hemorrhage in east Finland, 1977-1990.

A Ronkainen1, J Hernesniemi, M Ryynänen.   

Abstract

The familial occurrence of cerebral aneurysms in a defined clinical group of 1150 patients from a defined catchment area was studied. Two or more proven aneurysmal subarachnoid hemorrhage (SAH) patients within the same family were included. Of these 1150 patients, 113 (10%) had a proven familial occurrence of aneurysmal SAH. These 113 patients form 91 SAH families with a total of 203 aneurysm patients. Fifty-four percent of the patients were female, and the mean age in female patients was 49 years and in male patients was 44 years. In 23% of the families, three or more members were identified as having cerebral aneurysms. Middle cerebral artery aneurysms were the most common type (47%). Based on the high incidence (10%) of familial intracranial aneurysms among SAH patients, a prospective study of healthy family members for incidental intracranial aneurysms was performed, with positive findings of 12%.

Entities:  

Mesh:

Year:  1993        PMID: 8264874     DOI: 10.1227/00006123-199311000-00001

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  13 in total

1.  Sequencing of TGF-beta pathway genes in familial cases of intracranial aneurysm.

Authors:  Teresa Santiago-Sim; Sumy Mathew-Joseph; Hariyadarshi Pannu; Dianna M Milewicz; Christine E Seidman; J G Seidman; Dong H Kim
Journal:  Stroke       Date:  2009-03-19       Impact factor: 7.914

2.  Family history of subarachnoid haemorrhage: supplemental value of scrutinizing all relatives.

Authors:  P Greebe; J E Bromberg; G J Rinkel; A Algra; J van Gijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-03       Impact factor: 10.154

3.  THSD1 (Thrombospondin Type 1 Domain Containing Protein 1) Mutation in the Pathogenesis of Intracranial Aneurysm and Subarachnoid Hemorrhage.

Authors:  Teresa Santiago-Sim; Xiaoqian Fang; Morgan L Hennessy; Stephen V Nalbach; Steven R DePalma; Ming Sum Lee; Steven C Greenway; Barbara McDonough; Georgene W Hergenroeder; Kyla J Patek; Sarah M Colosimo; Krista J Qualmann; John P Hagan; Dianna M Milewicz; Calum A MacRae; Susan M Dymecki; Christine E Seidman; J G Seidman; Dong H Kim
Journal:  Stroke       Date:  2016-11-15       Impact factor: 7.914

4.  Screening for intracranial aneurysms. Paper is ambiguous about number with proven aneurysm.

Authors:  W I Schievink
Journal:  BMJ       Date:  1995-11-04

Review 5.  Subarachnoid haemorrhage: epidemiology, risk factors, and treatment options.

Authors:  G J Kaptain; G Lanzino; N F Kassell
Journal:  Drugs Aging       Date:  2000-09       Impact factor: 3.923

6.  A 54-year-old man with 12 intracranial aneurysms and familial subarachnoid hemorrhage: case report.

Authors:  Sayied Abdol Mohieb Hosainey; Torstein R Meling
Journal:  Neurosurg Rev       Date:  2016-07-25       Impact factor: 3.042

7.  Anticipation and phenotype in familial intracranial aneurysms.

Authors:  Y M Ruigrok; G J E Rinkel; C Wijmenga; J Van Gijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-10       Impact factor: 10.154

8.  Intracranial aneurysms in Finnish families: confirmation of linkage and refinement of the interval to chromosome 19q13.3.

Authors:  Monique van der Voet; Jane M Olson; Helena Kuivaniemi; Doreen M Dudek; Magdalena Skunca; Antti Ronkainen; Mika Niemelä; Juha Jääskeläinen; Juha Hernesniemi; Katariina Helin; Eira Leinonen; Moumita Biswas; Gerard Tromp
Journal:  Am J Hum Genet       Date:  2004-02-06       Impact factor: 11.025

9.  Subarachnoid haemorrhage in first and second degree relatives of patients with subarachnoid haemorrhage.

Authors:  J E Bromberg; G J Rinkel; A Algra; P Greebe; C M van Duyn; D Hasan; M Limburg; H W ter Berg; E F Wijdicks; J van Gijn
Journal:  BMJ       Date:  1995-07-29

Review 10.  The genetics of vascular complications in autosomal dominant polycystic kidney disease (ADPKD).

Authors:  Sandro Rossetti; Peter C Harris
Journal:  Curr Hypertens Rev       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.